A carregar...

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer (NSCLC)

IMPORTANCE: Early phase trials with monoclonal antibodies targeting PD-1/PD-L1 have demonstrated durable clinical responses in patients with NSCLC, however, current assays for the prognostic/predictive role of tumor PD-L1 expression are not standardized with respect to either quantity or distributio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: McLaughlin, Joseph, Han, Gang, Schalper, Kurt A., Carvajal-Hausdorf, Daniel, Pelakanou, Vasiliki, Rehman, Jamaal, Velcheti, Vamsidhar, Herbst, Roy, LoRusso, Patricia, Rimm, David L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941982/
https://ncbi.nlm.nih.gov/pubmed/26562159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.3638
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!